๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Thomas Smith

Stock Analyst at Leerink Partners

(4.99)
# 39
Out of 5,184 analysts
705
Total ratings
54%
Success rate
44.2%
Average return

Stocks Rated by Thomas Smith

Evommune
Nov 16, 2026
Reiterated: Buy
Price Target: $22
Current: $7.04
Upside: +212.50%
MoonLake Immunotherapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $30
Current: $11.07
Upside: +171.00%
Equillium
Nov 13, 2026
Reiterated: Buy
Price Target: $6
Current: $1.06
Upside: +466.04%
Sagimet Biosciences
Nov 13, 2026
Reiterated: Buy
Price Target: $26
Current: $9.08
Upside: +186.34%
Zura Bio
Nov 9, 2026
Reiterated: Buy
Price Target: $11 → $5
Current: $0.9305
Upside: +437.35%
X4 Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $12
Current: $3.00
Upside: +300.00%
Inventiva
Oct 29, 2026
Reiterated: Buy
Price Target: $12
Current: $3.14
Upside: +282.17%
Disc Medicine
Oct 27, 2026
Rated: Buy
Price Target: $100 → $130
Current: $75.14
Upside: +73.01%
argenx SE
Oct 9, 2026
Reiterated: Buy
Price Target: $1,065 → $1,115
Current: $925.70
Upside: +20.45%
Celldex Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $70 → $88
Current: $27.42
Upside: +220.93%
Rated: Buy
Price Target: $106 → $128
Current: $93.47
Upside: +36.94%
Reiterated: Buy
Price Target: $35 → $23
Current: $11.08
Upside: +107.58%
Reiterated: Buy
Price Target: $10
Current: $1.33
Upside: +651.88%
Initiated Coverage: Buy
Price Target: $38
Current: $6.76
Upside: +462.13%
Reiterated: Buy
Price Target: n/a
Current: $9.19
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $6.14
Upside: -
Reiterated: Buy
Price Target: $32
Current: $3.96
Upside: +708.08%
Reiterated: Buy
Price Target: $50
Current: $29.96
Upside: +66.89%
Reiterated: Buy
Price Target: $52 → $50
Current: $31.77
Upside: +57.38%
Initiated Coverage: Buy
Price Target: $36
Current: $5.45
Upside: +560.55%
Reiterated: Buy
Price Target: n/a
Current: $0.59
Upside: -
Reiterated: Buy
Price Target: $25 → $32
Current: $4.26
Upside: +651.17%
Initiated Coverage: Buy
Price Target: krย 102.00
Current: krย 45.14
Upside: +125.96%
Reiterated: Buy
Price Target: $118
Current: $24.77
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $2.81
Upside: n/a
Reiterated: Buy
Price Target: $7
Current: $3.44
Upside: n/a
Reiterated: Buy
Price Target: $104 → $115
Current: $73.20
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $379.10
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $1.78
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $8.34
Upside: n/a
Reiterated: Buy
Price Target: $58
Current: $14.93
Upside: n/a
Reiterated: Hold
Price Target: $5
Current: $6.99
Upside: n/a
Reiterated: Buy
Price Target: $6
Current: $13.35
Upside: n/a
Reiterated: Hold
Price Target: $33
Current: $115.31
Upside: n/a
Reiterated: Buy
Price Target: $7
Current: $3.85
Upside: n/a
Reiterated: Buy
Price Target: $46
Current: $0.5951
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $10.75
Upside: n/a
Downgraded: Hold
Price Target: $13 → $2
Current: $23.22
Upside: n/a
Reiterated: Buy
Price Target: 5,312p
Current: 114p
Upside: n/a
Initiated Coverage: Hold
Price Target: $21
Current: $7.05
Upside: n/a
Initiated Coverage: Hold
Price Target: $6
Current: $1.71
Upside: n/a